In-vitro Mutagenesis
Genetic Screens
Conservative Site-specific Recombination and Phase Variation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 27, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Jennifer L Cooper1, Bradley J Till, Steven Henikoff
1Howard Hughes Medical Institute and Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.
Ethyl methanesulfonate (EMS) mutagenesis is key for genetic screens. The Fly-TILL service uses Targeting Induced Local Lesions IN Genomes (TILLING) to provide Drosophila point mutations, revealing insights into genetic resource population dynamics.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: